Literature DB >> 10677295

Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene.

J Vockley1, P K Rogan, B D Anderson, J Willard, R S Seelan, D I Smith, W Liu.   

Abstract

Isovaleric acidemia (IVA) is a recessive disorder caused by a deficiency of isovaleryl-CoA dehydrogenase (IVD). We have reported elsewhere nine point mutations in the IVD gene in fibroblasts of patients with IVA, which lead to abnormalities in IVD protein processing and activity. In this report, we describe eight IVD gene mutations identified in seven IVA patients that result in abnormal splicing of IVD RNA. Four mutations in the coding region lead to aberrantly spliced mRNA species in patient fibroblasts. Three of these are amino acid altering point mutations, whereas one is a single-base insertion that leads to a shift in the reading frame of the mRNA. Two of the coding mutations strengthen pre-existing cryptic splice acceptors adjacent to the natural splice junctions and apparently interfere with exon recognition, resulting in exon skipping. This mechanism for missplicing has not been reported elsewhere. Four other mutations alter either the conserved gt or ag dinucleotide splice sites in the IVD gene. Exon skipping and cryptic splicing were confirmed by transfection of these mutations into a Cos-7 cell line model splicing system. Several of the mutations were predicted by individual information analysis to inactivate or significantly weaken adjacent donor or acceptor sites. The high frequency of splicing mutations identified in these patients is unusual, as is the finding of missplicing associated with missense mutations in exons. These results may lead to a better understanding of the phenotypic complexity of IVA, as well as provide insight into those factors important in defining intron/exon boundaries in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677295      PMCID: PMC1288088          DOI: 10.1086/302751

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  On the mechanism of dehydrogenation of fatty acyl derivatives of coenzyme A. II. The electron-transferring flavoprotein.

Authors:  F L CRANE; H BEINERT
Journal:  J Biol Chem       Date:  1956-02       Impact factor: 5.157

2.  Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. Identification of a new 2-methyl branched chain acyl-CoA dehydrogenase.

Authors:  Y Ikeda; C Dabrowski; K Tanaka
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

3.  Information analysis of human splice site mutations.

Authors:  P K Rogan; B M Faux; T D Schneider
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers.

Authors:  B R Graveley; K J Hertel; T Maniatis
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

5.  Spectroscopic analysis of the interaction of rat liver short-chain, medium-chain, and long-chain acyl coenzyme A dehydrogenases with acyl coenzyme A substrates.

Authors:  Y Ikeda; K Okamura-Ikeda; K Tanaka
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

6.  Biosynthesis of variant medium chain acyl-CoA dehydrogenase in cultured fibroblasts from patients with medium chain acyl-CoA dehydrogenase deficiency.

Authors:  Y Ikeda; D E Hale; S M Keese; P M Coates; K Tanaka
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

7.  Molecular heterogeneity of variant isovaleryl-CoA dehydrogenase from cultured isovaleric acidemia fibroblasts.

Authors:  Y Ikeda; S M Keese; K Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Biosynthesis of four rat liver mitochondrial acyl-CoA dehydrogenases: in vitro synthesis, import into mitochondria, and processing of their precursors in a cell-free system and in cultured cells.

Authors:  Y Ikeda; S M Keese; W A Fenton; K Tanaka
Journal:  Arch Biochem Biophys       Date:  1987-02-01       Impact factor: 4.013

9.  Mechanism of action of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases. Direct evidence for carbanion formation as an intermediate step using enzyme-catalyzed C-2 proton/deuteron exchange in the absence of C-3 exchange.

Authors:  Y Ikeda; D G Hine; K Okamura-Ikeda; K Tanaka
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

10.  Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia.

Authors:  A W Mohsen; B D Anderson; S L Volchenboum; K P Battaile; K Tiffany; D Roberts; J J Kim; J Vockley
Journal:  Biochemistry       Date:  1998-07-14       Impact factor: 3.162

View more
  18 in total

1.  Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.

Authors:  James R Ellis; Bianca Heinrich; Victor-F Mautner; Lan Kluwe
Journal:  Genes Chromosomes Cancer       Date:  2011-05-11       Impact factor: 5.006

2.  Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.

Authors:  A Gaedigk; A Bhathena; L Ndjountché; R E Pearce; S M Abdel-Rahman; S W Alander; L DiAnne Bradford; P K Rogan; J Steven Leeder
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

3.  Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.

Authors:  María L Couce; Luís Aldamiz-Echevarría; María A Bueno; Patricia Barros; Amaya Belanger-Quintana; Javier Blasco; María-Teresa García-Silva; Ana M Márquez-Armenteros; Isidro Vitoria; Inmaculada Vives; Rosa Navarrete; Ana Fernández-Marmiesse; Belén Pérez; Celia Pérez-Cerdá
Journal:  J Hum Genet       Date:  2016-12-01       Impact factor: 3.172

Review 4.  Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity.

Authors:  Jerry Vockley; Regina Ensenauer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

5.  Different spectrum of mutations of isovaleryl-CoA dehydrogenase (IVD) gene in Korean patients with isovaleric acidemia.

Authors:  Yong-Wha Lee; Dong Hwan Lee; Jerry Vockley; Nam-Doo Kim; You Kyoung Lee; Chang-Seok Ki
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

6.  A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening.

Authors:  Regina Ensenauer; Jerry Vockley; Jan-Marie Willard; Joseph C Huey; Jörn Oliver Sass; Steven D Edland; Barbara K Burton; Susan A Berry; René Santer; Sarah Grünert; Hans-Georg Koch; Iris Marquardt; Piero Rinaldo; Sihoun Hahn; Dietrich Matern
Journal:  Am J Hum Genet       Date:  2004-10-14       Impact factor: 11.025

7.  Genomic features defining exonic variants that modulate splicing.

Authors:  Adam Woolfe; James C Mullikin; Laura Elnitski
Journal:  Genome Biol       Date:  2010-02-16       Impact factor: 13.583

8.  Variation in the HLA-G promoter region influences miscarriage rates.

Authors:  Carole Ober; Carrie L Aldrich; Inna Chervoneva; Christine Billstrand; Fedik Rahimov; Heather L Gray; Terry Hyslop
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

9.  Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Authors:  Hiroki Inui; Kyu-Seon Oh; Carine Nadem; Takahiro Ueda; Sikandar G Khan; Ahmet Metin; Engin Gozukara; Steffen Emmert; Hanoch Slor; David B Busch; Carl C Baker; John J DiGiovanna; Deborah Tamura; Cornelia S Seitz; Alexei Gratchev; Wen Hao Wu; Kee Yang Chung; Hye Jin Chung; Esther Azizi; Roger Woodgate; Thomas D Schneider; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

10.  Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.

Authors:  A Rincón; C Aguado; L R Desviat; R Sánchez-Alcudia; M Ugarte; B Pérez
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.